3-phase deployment roadmap for TracHeal within the Dubai Health Authority hospital network
Measurable outcomes we commit to tracking from Day 1 of the pilot
Deploy TracHeal at one DHA hospital (e.g., Rashid Hospital or Dubai Hospital) targeting the cardiology and diabetes discharge pathway — the two highest-volume chronic disease readmission categories in the UAE.
Scale to 3 DHA hospitals and integrate with Wareed (DHA's unified health information system) for automated data ingestion — eliminating manual paste workflow.
Expand beyond DHA to private hospital groups (e.g., Aster DM Healthcare, Mediclinic Middle East) and begin multi-emirate rollout. Regulatory alignment with MOHAP for commercial deployment.
Anticipated obstacles and our plan to address them
| Risk | Impact | Mitigation |
|---|---|---|
| EHR integration delays | High | Phase 1 uses manual text input (no integration dependency). Wareed integration begins in Phase 2 with DHA technical liaison. |
| Clinician adoption resistance | Medium | Co-design with care coordinators from Week 1. TracHeal fits into existing workflow — not a new tool, but intelligence layered onto current discharge process. |
| Data privacy regulatory block | High | All data stays within DHA network boundary. Privacy-by-design architecture reviewed by DHA information governance team before pilot launch. |
| AI hallucination / incorrect alerts | High | Clinician-in-the-loop: every AI output reviewed by care coordinator before action. RAG architecture grounds outputs in source documents. Alert links to original record. |
| Low patient engagement with alerts | Medium | Multilingual alerts (Arabic + English). SMS as default channel (highest reach in UAE). Caregiver opt-in for elderly patients. |
Regulator for all healthcare facilities in Dubai. Sets quality KPIs including readmission targets. Operates Wareed (unified HIS). TracHeal aligns with DHA's digital health transformation strategy.
Federal regulator. UAE Federal Law No. 2 of 2019 governs health data protection. MOHAP approval required for commercial health AI deployment. Phase 3 includes formal regulatory submission.